Semaglutide drug Wegovy has been available in New Zealand for a couple of months now, and more Kiwis are learning about the effects.
The drug has transformed our ability to manage obesity and type 2 diabetes, and has shown potential for a wide range of conditions such as Alzheimer’s, addiction and depression.
General Practice NZ chair Dr Bryan Betty joined the Afternoons team to discuss further - and highlight some potential drawbacks.
LISTEN ABOVE

Full Show Podcast: 29 May 2026
1:55:44

Matt and Tyler's New Zealander of the Week - 29 May
04:58

Chelsie Preston Crayford: Director chats new 'auto-fiction' flick Caterpillar
11:01